Literature DB >> 2318008

Prediction of drug distribution into human milk from physicochemical characteristics.

H C Atkinson1, E J Begg.   

Abstract

Decisions about the safety of breast feeding during maternal ingestion of drugs require knowledge of the amount of drug which might be present in the milk. For many drugs this has not been studied, and mothers are usually advised against breast feeding. In many cases this is undoubtedly unnecessary, as the total dose to which the baby is exposed is often negligible. It would be very helpful, therefore, to be able to predict the approximate amount of drug which might be present in milk. Existing theory of pH partitioning enables estimation of the distribution of unbound drug, i.e. milk: plasma unbound ratios. However, these ratios are poor estimates of the concentration ratios for whole milk, because whole milk contains proteins and lipid in which drugs will distribute in amounts which depend on their particular physicochemical properties. To predict the milk: plasma concentration ratios for whole milk the amount of drug present in the protein and lipid phases must be considered along with the unbound drug distribution. A 'phase distribution model' has therefore been developed which permits estimation of whole milk: plasma concentration ratios. The model requires a knowledge of the unbound drug concentration ratio, the plasma and milk unbound fractions and the milk lipid: ultrafiltrate partition coefficient. Evaluation of the model by comparison of predicted whole milk ratio values with literature milk: plasma area under the curve (AUC) ratios indicated a trend to overprediction for acidic and neutral drugs and underprediction for basic drugs. Transformation of the phase distribution equation by taking logarithms results in a relationship which can be analysed by multiple linear regression to derive predictive equations for acidic and basic drugs which take into account the relative contributions of each component of the model. Regression of the logarithms of the literature milk: plasma AUC values against the independent variables resulted in good correlations for acidic and basic drugs. The independent variables explained 93.1% and 82.9% of the variance in the values for acidic and basic drugs, respectively, with random scatter of residuals. The equations, together with those to predict unbound fractions of drug in milk and milk lipid: ultrafiltrate partition coefficients, enable the ratio of the milk: plasma AUCs to be estimated for any acidic or basic drug for which the distribution into human milk is not known, using the pKa, octanol: water partition coefficient and plasma protein binding values of the drug. The data set for neutral drugs (n = 3) was too small to develop a correlation equation.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2318008     DOI: 10.2165/00003088-199018020-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  80 in total

1.  Relationship of octanol/water partition coefficient and molecular weight to cellular permeability and partitioning in s49 lymphoma cells.

Authors:  V A Levin; D Dolginow; H D Landahl; C Yorke; J Csejtey
Journal:  Pharm Res       Date:  1984-11       Impact factor: 4.200

2.  A longitudinal study of the protein, nitrogen, and lactose contents of human milk from Swedish well-nourished mothers.

Authors:  B Lönnerdal; E Forsum; L Hambraeus
Journal:  Am J Clin Nutr       Date:  1976-10       Impact factor: 7.045

3.  Excretion of diltiazem in human milk.

Authors:  M Okada; H Inoue; Y Nakamura; M Kishimoto; T Suzuki
Journal:  N Engl J Med       Date:  1985-04-11       Impact factor: 91.245

Review 4.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

5.  Atenolol and metoprolol. A comparison of their excretion into human breast milk.

Authors:  J Kulas; N O Lunell; U Rosing; B Stéen; A Rane
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1984

Review 6.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

7.  Mexiletine in human blood and breast milk.

Authors:  A M Lewis; L Patel; A Johnston; P Turner
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

Review 8.  Clinical consequences of the lipophilicity and plasma protein binding of antiarrhythmic drugs and active metabolites in man.

Authors:  D E Drayer
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

9.  Analgesic drugs in breast milk and plasma.

Authors:  J W Findlay; R L DeAngelis; M F Kearney; R M Welch; J M Findlay
Journal:  Clin Pharmacol Ther       Date:  1981-05       Impact factor: 6.875

10.  The binding of prednisolone in human serum and to recrystallized human albumin in vitro.

Authors:  W H Steele; G M Hawksworth; H E Barber
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

View more
  28 in total

Review 1.  Antibiotics and breast-feeding: a critical review of the literature.

Authors:  Allison M Chung; Michael D Reed; Jeffrey L Blumer
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 2.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

3.  Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics.

Authors:  E J Begg; H C Atkinson; S B Duffull
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

4.  Prediction of milk/plasma drug concentration (M/P) ratio using support vector machine (SVM) method.

Authors:  Chunyan Zhao; Haixia Zhang; Xiaoyun Zhang; Ruisheng Zhang; Feng Luan; Mancang Liu; Zhide Hu; Botao Fan
Journal:  Pharm Res       Date:  2006-11-30       Impact factor: 4.200

5.  Cimetidine does not appear to influence the distribution of metformin into human milk.

Authors:  Sharon J Gardiner; Carl M J Kirkpatrick; Mei Zhang; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2008-06-09       Impact factor: 4.335

6.  Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.

Authors:  Kenneth F Ilett; Judith H Kristensen; L Peter Hackett; Michael Paech; Rolland Kohan; Jonathan Rampono
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

Review 7.  Biological barriers, and the influence of protein binding on the passage of drugs across them.

Authors:  Karolina Wanat
Journal:  Mol Biol Rep       Date:  2020-03-05       Impact factor: 2.316

Review 8.  Drugs in Lactation.

Authors:  Philip O Anderson
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

9.  Distribution and excretion of fluoxetine and norfluoxetine in human milk.

Authors:  J H Kristensen; K F Ilett; L P Hackett; P Yapp; M Paech; E J Begg
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 10.  Effect of pregnancy on the pharmacokinetics of antihypertensive drugs.

Authors:  Gail D Anderson; Darcy B Carr
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.